1. Progress to date and Plans for Year 5 Overcoming HIV/AIDS epidemic in Ukraine Programme supported by the Global Fund 11 th Stakeholders’ meeting 22 nd of June, 2007 Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine

2. Main achievements (as of April 01,2007) www.aidsalliance.org.ua  4 060 persons (3 464 adults and 596 children) take the vitally important antiretroviral therapy (АRТ)  5 090 of HIV-positive pregnant women received ART to prevent the HIV-transmission from mother to child during birth (cumulatively since 2004)  522 injecting drug users access substitution maintenance treatment (SMT)  406 clinical facilities across Ukraine obtained medicines and other health products  The groups most vulnerable to HIV-infection received prevention services and information 117 942 IDUs 16 516 sex workers 16 516 sex workers 33 239 prisoners 33 239 prisoners The coverage access prevention services

3. Implementation of the antiretroviral therapy in Ukraine by the sources of funding www.aidsalliance.org.ua Global Fund State Budget Other sources

4. Major challenges at this stage and actions taken: www.aidsalliance.org.ua Recall of Viracept  Immediate note of the Alliance to the Ukrainian authorities and quick communication to all essential stakeholders  Decision on replacing Viracept with Kaletra  Quick acting on placing the order with IDA  Ensuring that all necessary formalities are made Delay with rolling out substitution maintenance treatment (SMT) with methadone  Involvement in the MOH Order development, advocacy for signing the order  Support preparation of facilities where the therapy will be provided (48 sites)  Quick preparations of the documents and support of all other involved institutions in order to obtain the import quota for Ukraine  Quota procedure may delay actual rolling out of SMT

5. Ambitious 2008 targets www.aidsalliance.org.ua  6,000 patients on ART  6,000 IDUs on ST (1250 of which also on ART);  12,200 pregnant women receive PMTCT;  26,300 PLHA access non-clinical care & support  150,000 IDUs  15,000 sex workers access prevention services  19,200 prisoners

6. Comparison budget table www.aidsalliance.org.ua

7. Proposed Year 5 budget to Approved Year 5 budget Proposed Year 5 budget to Approved Year 5 budget www.aidsalliance.org.ua Main Programme objectives Activity Description Approved Year 5 budget Proposed year 5 budget Variance as to approved budget Variance (%) 1Establishment and maintenance of PR Unit2 630 8382 883 465252 627110% 2 Treatment, care and support (including procurement of ARV and other medical supplies) 13 976 66812 945 690-1 030 97893% 3Focused prevention3 676 4473 978 346301 899108% 4Information, education and advocacy2 376 4452 320 459-55 98698% 5Surveillance and evaluation646 072735 44689 374114% 6Alliance management fee500 000 0100% TOTAL23 806 47023 363 407-443 06398% All costs presented in USD

8. Consolidated Budget - Revised Euro Budget, Prepared June 2007 www.aidsalliance.org.ua Main Programme objectives Activity Description Year 3 Spend Proposed Year 4 Budget June 07 Proposed Year 5 Budget June 07 Total Year 3 – Year 5 1 Establishment and maintenance of PR Unit 1 445 2521 942 9802 166 0595 554 292 2 Treatment, care and support (including procurement of ARV and other medical supplies) 8 796 15910 666 5819 724 80229 187 542 3Focused prevention3 001 5993 426 9922 988 5349 417 124 4Information, education and advocacy1 730 5831 801 6901 743 1295 275 402 5Surveillance and evaluation467 732520 763552 4671 540 963 6Alliance management fee412 413380 284375 6001 168 298 TOTAL15 853 73818 739 29117 550 59252 143 620 Amount of the agreement in EURO:55 567 407 Total Year 3 - Year 5 in EURO:52 143 620 Potentially available for no cost extension (EURO):3 423 787

9. www.aidsalliance.org.ua Round 1 to Round 6 complimentarity

10. No-cost extension priorities www.aidsalliance.org.ua  Drugs for substitution therapy  Support programmes for the ST clients  Support for ARV Adherence  Administrative support

11. Key principles of the Y5 planning www.aidsalliance.org.ua  Harmonization with Round 6 programme, addressing potential funding gap between October 2008 – June 2009.  Build confidence that all the patients that ill receive ARV treatment and PMTCT within the Round 1 framework will continue treatment after September 2008 with governmental funding.  Addressing programme challenges e.g. ARV treatment dropouts, growing needs in substitution therapy, and coverage of most at risk populations and PLHA  Recommendations from the external evaluation of the grant will be applied for the current and Round 6 grants as well as for the overall country response  Ensure meeting all the targets